Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: Relationship to S-100B levels and blood-brain barrier function

Clinica Chimica Acta

Volumn 400, Issue 1-2, 2009, Pages 86-90

  Gressner, Olav A ^a   Schifflers, Marie Claire ^a   Kim, Philipp ^a   Heuts, Leo ^a   Lahme, Birgit ^a   Gressner, Axel M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Actinfree Gc Globulin; Blood brain barrier; Clinical outcome; CNS injury; S100

Indexed keywords

ACTIN; PROTEIN S100B; VITAMIN D BINDING PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INJURY; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CHILD; CONCENTRATION (PARAMETERS); DEGENERATIVE DISEASE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NERVE INJURY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL;

ACTINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD-BRAIN BARRIER; BRAIN INJURIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; S100 PROTEINS; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D-BINDING PROTEIN;

EID: 57949084772     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.10.015     Document Type: Article

References (36)

1. Fuchs E. The cytoskeleton and disease: genetic disorders of intermediate filaments. Annu Rev Genet 30 (1996) 197-231
2. Moreau V., and Way M. In vitro approaches to study actin and microtubule dependent cell processes. Curr Opin Cell Biol 11 (1999) 152-158
3. Baron W., de Jonge J.C., de Vries H., and Hoekstra D. Perturbation of myelination by activation of distinct signaling pathways: an in vitro study in a myelinating culture derived from fetal rat brain. J Neurosci Res 59 (2000) 74-85
4. Rando O.J., Zhao K., and Crabtree G.R. Searching for a function for nuclear actin. Trends Cell Biol 10 (2000) 92-97
5. Doussau F., and Augustine G.J. The actin cytoskeleton and neurotransmitter release: an overview. Biochimie 82 (2000) 353-363
6. Shaw P.J., and Williams R. Serum and cerebrospinal fluid biochemical markers of ALS. Amyotroph Lateral Scler Other Mot Neuron Disord 1 (2000) S61-67
7. Merched A., Serot J.M., Visvikis S., Aguillon D., Faure G., and Siest G. Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry. FEBS Lett 425 (1998) 225-228
8. Chauhan V.P., Ray I., Chauhan A., and Wisniewski H.M. Binding of gelsolin, a secretory protein, to amyloid beta-protein. Biochem Biophys Res Commun 258 (1999) 241-246
9. Semra Y.K., Seidi O.A., and Sharief M.K. Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability. J Neuroimmunol 122 (2002) 132-139
10. Harper K.D., McLeod J.F., Kowalski M.A., and Haddad J.G. Vitamin D binding protein sequesters monomeric actin in the circulation of the rat. J Clin Invest 79 (1987) 1365-1370
11. Cooke N.E., and Haddad J.G. Vitamin D binding protein (Gc-globulin). Endocr Rev 10 (1989) 294-307
12. Constans J. Group-specific component is not only a vitamin-D-binding protein. Exp Clin Immunogenet 9 (1992) 161-175
13. Haddad J.G. Plasma vitamin D-binding protein (Gc-globulin): multiple tasks. J Steroid Biochem Mol Biol 53 (1995) 579-582
14. White P., and Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 11 (2000) 320-327
15. Meier U., Gressner O., Lammert F., and Gressner A.M. Gc-globulin: roles in response to injury. Clin Chem 52 (2006) 1247-1253
16. Lee W.M., Galbraith R.M., Watt G.H., et al. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology 21 (1995) 101-105
17. Schiodt F.V., Bondesen S., Petersen I., Dalhoff K., Ott P., and Tygstrup N. Admission levels of serum Gc-globulin: predictive value in fulminant hepatic failure. Hepatology 23 (1996) 713-718
18. Schiodt F.V., Rossaro L., Stravitz R.T., Shakil A.O., Chung R.T., and Lee W.M. Gc-globulin and prognosis in acute liver failure. Liver Transpl 11 (2005) 1223-1227
19. Antoniades C.G., Berry P.A., Bruce M., et al. Actin-free Gc globulin: a rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis. Liver Transpl 13 (2007) 1254-1261
20. Schiodt F.V., Ott P., Tygstrup N., Dahl B., and Bondesen S. Temporal profile of total, bound, and free Gc-globulin after acetaminophen overdose. Liver Transpl 7 (2001) 732-738
21. Dahl B., Schiodt F.V., Ott P., et al. Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit Care Med 31 (2003) 152-156
22. Dahl B., Schiodt F.V., Kiaer T., Ott P., Bondesen S., and Tygstrup N. Serum Gc-globulin in the early course of multiple trauma. Crit Care Med 26 (1998) 285-289
23. Dahl B., Schiodt F.V., Rudolph S., Ott P., Kiaer T., and Heslet L. Trauma stimulates the synthesis of Gc-globulin. Intensive Care Med 27 (2001) 394-399
24. Dahl B. The extracellular actin scavenger system in trauma and major surgery. Clinical and experimental studies. Acta Orthop 76 (2005) 2 p preceding table of contents-24
25. Teasdale G., and Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 2 (1974) 81-84
26. Reiber H., and Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 163 (1987) 319-328
27. Link H., and Tibbling G. Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scand J Clin Lab Invest 37 (1977) 391-396
28. Mussack T., Biberthaler P., Kanz K.G., et al. Immediate S-100B and neuron-specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients. Shock 18 (2002) 395-400
29. Stroick M., Fatar M., Ragoschke-Schumm A., Fassbender K., Bertsch T., and Hennerici M.G. Protein S-100B-a prognostic marker for cerebral damage. Curr Med Chem 13 (2006) 3053-3060
30. Zhang J., Sokal I., Peskind E.R., et al. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol 129 (2008) 526-529
31. Korolainen M.A., Nyman T.A., Nyyssonen P., Hartikainen E.S., and Pirttila T. Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease. Clin Chem 53 (2007) 657-665
32. Rozek W., Ricardo-Dukelow M., Holloway S., et al. Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. J Proteome Res 6 (2007) 4189-4199
33. Liu X.D., Zeng B.F., Xu J.G., Zhu H.B., and Xia Q.C. Proteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniation. Proteomics 6 (2006) 1019-1028
34. Jiang L., Lindpaintner K., Li H.F., et al. Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia. Amino Acids 25 (2003) 49-57
35. Katikaneni L.P., Emerson D.L., Goldschmidt-Clermont P.J., Loadholt B.C., Levkoff A.H., and Galbraith R.M. High levels of group-specific component (vitamin-D-binding protein) in the cerebrospinal fluid of infants aged less than 2 months. Biol Neonate 52 (1987) 250-255
36. Mollgard K., Dziegielewska K.M., Saunders N.R., Zakut H., and Soreq H. Synthesis and localization of plasma proteins in the developing human brain. Integrity of the fetal blood-brain barrier to endogenous proteins of hepatic origin. Dev Biol 128 (1988) 207-221